Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Divyaanka Iyer

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Current Allergy and Asthma Reports|April 22, 2017
Mitochondrial Function in Allergic DiseaseDivyaanka Iyer, Navya Mishra, Anurag Agrawal
The FEBS Journal|July 6, 2021
Characterization of G4 DNA formation in mitochondrial DNA and their potential role in mitochondrial genome instabilitySumedha Dahal, Humaira Siddiqua, Vijeth K Katapadi, et al.
Biochemical Pharmacology|October 4, 2016
A novel inhibitor of BCL2, Disarib abrogates tumor growth while sparing platelets, by activating intrinsic pathway of apoptosisSupriya V Vartak, Mahesh Hegde, Divyaanka Iyer, et al.
Biochemical Pharmacology|February 23, 2017
Novel BCL2 inhibitor, Disarib induces apoptosis by disruption of BCL2-BAK interactionSupriya V Vartak, Divyaanka Iyer, T R Santhoshkumar, et al.
The FEBS Journal|July 23, 2016
Identification of a novel BCL2-specific inhibitor that binds predominantly to the BH1 domainDivyaanka Iyer, Supriya V Vartak, Archita Mishra, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Current Allergy and Asthma Reports|April 22, 2017
Mitochondrial Function in Allergic DiseaseDivyaanka Iyer, Navya Mishra, Anurag Agrawal
The FEBS Journal|July 6, 2021
Characterization of G4 DNA formation in mitochondrial DNA and their potential role in mitochondrial genome instabilitySumedha Dahal, Humaira Siddiqua, Vijeth K Katapadi, et al.
Biochemical Pharmacology|October 4, 2016
A novel inhibitor of BCL2, Disarib abrogates tumor growth while sparing platelets, by activating intrinsic pathway of apoptosisSupriya V Vartak, Mahesh Hegde, Divyaanka Iyer, et al.
Biochemical Pharmacology|February 23, 2017
Novel BCL2 inhibitor, Disarib induces apoptosis by disruption of BCL2-BAK interactionSupriya V Vartak, Divyaanka Iyer, T R Santhoshkumar, et al.
The FEBS Journal|July 23, 2016
Identification of a novel BCL2-specific inhibitor that binds predominantly to the BH1 domainDivyaanka Iyer, Supriya V Vartak, Archita Mishra, et al.
Pageof 1